Trial · NCT01893632
Gabapentin Treatment of Benzodiazepine Dependence
NCT01893632, Phase 2, Terminated, New York State Psychiatric Institute; results first posted 2018-07-24
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Gabapentin Treatment of Benzodiazepine Dependence. Trials, record NCT01893632. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01893632
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Gabapentin Treatment of Benzodiazepine Dependence
- NCT number
- NCT01893632
- Status
- Terminated
- Phases
- Phase 2
- Enrollment
- 2 participants, actual
- Lead sponsor
- New York State Psychiatric Institute
- Conditions
- Benzodiazepine Dependence
- Interventions
- gabapentin, Placebo
- First posted
- 2013-07-09
- Last updated
- 2019-04-24
- Results first posted
- 2018-07-24
- Limitations and caveats
- due to poor recruitment, enrollment was limited to two participants and trial was terminated.
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Abstinence From Benzodiazepine Use | last two weeks of 12 week trial | Achievement of two weeks abstinence from benzodiazepine use at end of trial |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Abstinence From Benzodiazepine Use | last two weeks of 12 week trial | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Abstinence From Benzodiazepine Use | Gabapentin | 0 | Participants | ||
| Abstinence From Benzodiazepine Use | Placebo | 0 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Gabapentin | 1 | |
| Overall Study | STARTED | Placebo | 1 | |
| Overall Study | COMPLETED | Gabapentin | 1 | |
| Overall Study | COMPLETED | Placebo | 1 | |
| Overall Study | NOT COMPLETED | Gabapentin | 0 | |
| Overall Study | NOT COMPLETED | Placebo | 0 |
Source ClinicalTrials.gov
Adverse events16
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | anxiety | General disorders | Gabapentin | 0 | 1 | 0 |
| other | anxiety | General disorders | Placebo | 1 | 1 | 1 |
| other | appetite change | Gastrointestinal disorders | Gabapentin | 0 | 1 | 0 |
| other | appetite change | Gastrointestinal disorders | Placebo | 1 | 1 | 1 |
| other | nausea | Gastrointestinal disorders | Gabapentin | 0 | 1 | 0 |
| other | nausea | Gastrointestinal disorders | Placebo | 1 | 1 | 1 |
| other | unsteady gait | Musculoskeletal and connective tissue disorders | Gabapentin | 1 | 1 | 1 |
| other | unsteady gait | Musculoskeletal and connective tissue disorders | Placebo | 0 | 1 | 0 |
| other | chest tightness | General disorders | Gabapentin | 0 | 1 | 0 |
| other | chest tightness | General disorders | Placebo | 1 | 1 | 1 |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 adverse eventsAdverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Gabapentin | 0 | 1 |
| Total, all-cause mortality | Placebo | 0 | 1 |
| Total, other adverse events | Gabapentin | 1 | 1 |
| Total, other adverse events | Placebo | 1 | 1 |
| Total, serious adverse events | Gabapentin | 0 | 1 |
| Total, serious adverse events | Placebo | 0 | 1 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Gabapentin vs Placebo: Abstinence From Benzodiazepine Use | Trial comparisons |
| Gabapentin vs Placebo: deaths from any cause | Trial comparisons |
| Gabapentin vs Placebo: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01893632
GET https://conductscience.org/api/trials/v1/NCT01893632/registered